Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy. (Record no. 24125605)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02124 a2200613 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516231100.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201602s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1600-0641 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/j.jhep.2014.08.021 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Marcellin, Patrick |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20160225 |
| 245 00 - TITLE STATEMENT | |
| Title | Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Journal of hepatology |
| Date of publication, distribution, etc. | Jan 2015 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 41-7 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antiviral Agents |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | DNA, Viral |
| General subdivision | analysis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Carriers |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Therapy, Combination |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Global Health |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepatitis B e Antigens |
| General subdivision | immunology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepatitis B virus |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepatitis B, Chronic |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Incidence |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Interferon-alpha |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Peripheral Nervous System Diseases |
| General subdivision | diagnosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Polyethylene Glycols |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Recombinant Proteins |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Telbivudine |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Thymidine |
| General subdivision | adverse effects |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wursthorn, Karsten |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wedemeyer, Heiner |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chuang, Wan-Long |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lau, George |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Avila, Claudio |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Peng, Cheng-Yuan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gane, Edward |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lim, Seng Gee |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fainboim, Hugo |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Foster, Graham R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Safadi, Rifaat |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rizzetto, Mario |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Manns, Michael |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bao, Weibin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Trylesinski, Aldo |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Naoumov, Nikolai |
| 773 0# - HOST ITEM ENTRY | |
| Title | Journal of hepatology |
| Related parts | vol. 62 |
| -- | no. 1 |
| -- | p. 41-7 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.jhep.2014.08.021">https://doi.org/10.1016/j.jhep.2014.08.021</a> |
| Public note | Available from publisher's website |
No items available.